Sponsored by:

Nuclear Medicine: Page 397

Mobile PET to launch mobile PET/CT service
By AuntMinnie.com staff writers
Mobile PET Systems has ordered a Siemens Medical Solutions' biograph PET/CT scanner to provide a combined PET/CT mobile service.
November 28, 2002
IPL debuts multimodality fusion imaging marker
By AuntMinnie.com staff writers
Nuclear medicine product developer Isotope Products Laboratories has released a sealed-source multimodality marker designed for fusion imaging.
November 26, 2002
Siemens lands large nuclear medicine order
By AuntMinnie.com staff writers
Siemens Medical Solutions has signed a purchase agreement with Carolinas HealthCare System of Charlotte, NC, for 12 E.Cam gamma cameras and two PET systems.
November 24, 2002
Heston PSA advocates PET use for Alzheimer’s detection
By AuntMinnie.com staff writers
Actor Charlton Heston has taped public service announcements for the Academy of Molecular Imaging.
November 20, 2002
P.E.T.Net to sponsor UC research
By AuntMinnie.com staff writers
P.E.T.Net Pharmaceuticals of Knoxville, TN, will sponsor a two-year University of California grant to support research related to protein tyrosine kinases (PTK) inhibitors for use in the staging and treatment of cancer.
November 19, 2002
PET firm CTI reports strong year-end results
By AuntMinnie.com staff writers
PET provider CTI Molecular Imaging reported fiscal fourth-quarter revenues of $86.5 million, up 15% from the $75.5 million in sales posted in the same period last year.
November 19, 2002
US Oncology adds to PET network
By AuntMinnie.com staff writers
US Oncology cancer centers in Texas and Illinois have added PET imaging capabilities.
November 17, 2002
Draxis Health’s Q3 revenues climb 10%
By AuntMinnie.com staff writers
Radiopharmaceutical firm Draxis Health reported third-quarter revenues from continuing operations of $8.9 million, up 10% compared with the $8.1 million posted in the same period last year.
November 13, 2002
Neoprobe’s Q3 revenues sag
By AuntMinnie.com staff writers
Gamma-probe developer Neoprobe reported third-quarter revenues of $920,000, down 51.5% compared with the $1.9 million in sales posted in the third quarter last year. The company attributed the loss to a decline in demand for its gamma-detection devices by its primary marketing partner, Ethicon Endo-Surgery.
November 12, 2002
Syncor expects 10-Q filing delay
By AuntMinnie.com staff writers
Radiopharmaceutical provider Syncor International said it expects to file a notification of late filing on Form 12b-25 with the Securities and Exchange Commission.
November 12, 2002
Cytogen returns to Nasdaq compliance
By AuntMinnie.com staff writers
Biopharmaceutical developer Cytogen said that it has been notified by the Nasdaq Stock Market that it has regained compliance with the Nasdaq’s listing standard for minimum bid price.
November 11, 2002
Immunomedics net loss widens in Q1
By AuntMinnie.com staff writers
Immunomedics reported 2003 fiscal first-quarter revenues of $3.2 million, down slightly compared to last year's numbers.
November 11, 2002
Previous Page
Page 397 of 439
Next Page